![]() | |
Clinical data | |
---|---|
Trade names | Viscotiol |
Other names | 2-[2-(ethoxycarbonylmethylsulfanyl)ethyl]-1,3-thiazolidine-4-carboxylic acid |
Routes of administration | Oral (gastroresistantcapsules) |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
CompTox Dashboard(EPA) | |
ECHA InfoCard | 100.053.509![]() |
Chemical and physical data | |
Formula | C10H17NO4S2 |
Molar mass | 279.37 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Letosteine is amucolytic[1]patented (U.S. patent 6987120) by Piero del Soldato ofMilan, Italy.[2] He filed his application in 2000.
![]() | Thisdrug article relating to therespiratory system is astub. You can help Wikipedia byexpanding it. |